Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734975 | SCV000863160 | uncertain significance | not provided | 2018-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325453 | SCV002607569 | uncertain significance | Cardiovascular phenotype | 2018-09-06 | criteria provided, single submitter | clinical testing | The p.I10452T variant (also known as c.31355T>C), located in coding exon 125 of the TTN gene, results from a T to C substitution at nucleotide position 31355. The isoleucine at codon 10452 is replaced by threonine, an amino acid with similar properties. This variant (also reported as p.I16949T) was detected in an individual reported to have arrhythmogenic right ventricular cardiomyopathy, but was also detected in the proband's unaffected parent (Taylor M et al. Circulation, 2011 Aug;124:876-85). This variant has been seen in an exome cohort, but cardiovascular history was not provided (Andreasen C et al. Eur. J. Hum. Genet., 2013 Sep;21:918-28). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV000734975 | SCV005201958 | uncertain significance | not provided | 2023-10-16 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; This variant is associated with the following publications: (PMID: 34426522, 32039858, 23299917, 31402444, 21810661) |